La cadena de opciones muestra datos clave de las opciones de acciones de Aptevo Therapeutics a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Aptevo Therapeutics..

Aptevo Therapeutics (NASDAQ:APVO) Bolsa, Cadena de Opciones

Aptevo Therapeutics

Aptevo Therapeutics Inc is a clinical-stage, research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidate, APVO436, and preclinical candidates, ALG.APV-527 and APVO603, were developed using ADAPTIR modular protein technology platform. The versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.

Aptevo Therapeutics Inc

Former President Donald Trump's unconventional campaign stop at a McDonald's drive-thru gave the Shiba Inu (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/shib/usd">SHIB</a>) community an opportunity to flex their meme muscle, as they used clever wordplays to call attention to the ecosystem's cryptocurrency tokens.
What happened: The Republican presidential nominee <a href="https://www.benzinga.com/news/24/10/41419892/trump-turns-up-to-serve-fries-at-mcdonalds-i-could-do-this-all-day-i-wouldnt-mind-this-job">was seen serving customers and operating the fry cooker</a> at the fast food joint in an effort to court working-class voters.
While the gimmick, or whatever one may call it, was for political reasons, the passionate Shiba Inu community used it to market meme coins associated with the project.
One such member, with the pseudonym Maximous Shibarium on X, said, "I prefer my meat with BONE," referring to BoneShibaSwap (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">BONE</a>).
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Hey <a href="https://twitter.com/elonmusk?ref_src=twsrc%5Etfw">@elonmusk</a> , do you know if <a href="https://twitter.com/realDonaldTrump?ref_src=twsrc%5Etfw">@realDonaldTrump</a> was allowed to serve ribs, McRib maybe? I prefer my meat with <a href="https://twitter.com/search?q=%24BONE&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$BONE</a> &#x1f356;<a href="https://twitter.com/hashtag/Shibarium?src=hash&amp;ref_src=twsrc%5Etfw">#Shibarium</a> users will need some <a href="https://twitter.com/hashtag/BONE?src=hash&amp;ref_src=twsrc%5Etfw">#BONE</a>, whole <a href="https://twitter.com/hashtag/ShibArmy?src=hash&amp;ref_src=twsrc%5Etfw">#ShibArmy</a> will!<a href="https://twitter.com/ShibariumNet?ref_src=twsrc%5Etfw">@ShibariumNet</a> <a href="https://twitter.com/Shibtoken?ref_src=twsrc%5Etfw">@Shibtoken</a> <a href="https://twitter.com/ShibaSwapDEX?ref_src=twsrc%5Etfw">@ShibaSwapDEX</a> <a href="https://twitter.com/TheShibmagazine?ref_src=twsrc%5Etfw">@TheShibmagazine</a> <a href="https://twitter.com/LucieSHIB?ref_src=twsrc%5Etfw">@LucieSHIB</a> <a href="https://twitter.com/ShytoshiKusama?ref_src=twsrc%5Etfw">@ShytoshiKusama</a> <a href="https://twitter.com/kaaldhairya?ref_src=twsrc%5Etfw">@kaaldhairya</a> <a href="https://t.co/GUkzmW8Fof">https://t.co/GUkzmW8Fof</a>
&mdash; Maximous &#x1f415;&#x1f356; Shibarium (@MaximousDarwin) <a href="https://twitter.com/MaximousDarwin/status/1848445466486444268?ref_src=twsrc%5Etfw">October 21, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Another SHIB advocate, operating under dhel&#x2A;SHIB l SHIB.io, wrote, "#TreatYourself to a McSHIB," in what was an intelligent wordplay around McDonald's famous pork sandwich and the Treat (TREAT) token.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true"><a href="https://twitter.com/hashtag/TreatYourself?src=hash&amp;ref_src=twsrc%5Etfw">#TreatYourself</a> to a McSHIB: &#x1f354;Your wallet deserves the full combo—$SHIB, <a href="https://twitter.com/search?q=%24BONE&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$BONE</a>, and <a href="https://twitter.com/search?q=%24LEASH&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$LEASH</a> for maximum growth!&#x1f415;&#x1f4a8;&#x1f525;&#x1f680;<a href="https://twitter.com/hashtag/ShibArmyStrong?src=hash&amp;ref_src=twsrc%5Etfw">#ShibArmyStrong</a> <a href="https://twitter.com/hashtag/Shibarium?src=hash&amp;ref_src=twsrc%5Etfw">#Shibarium</a> <a href="https://t.co/z5hr1iBkJR">pic.twitter.com/z5hr1iBkJR</a>
&mdash; dhel&#x2A;SHIB l SHIB.io &#x1f415;&#x1f4a8; (@dhelSHIB) <a href="https://twitter.com/dhelSHIB/status/1848435969139093644?ref_src=twsrc%5Etfw">October 21, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Even Kaal Dhairya, a top developer in the ecosystem, couldn't restrict participating in the trend.&nbsp;
"Imagine President Trump at McDonald's: Here's your order, and don't worry, we're making America great again—one Shib at a time!" Dhairya wrote in an X post, evoking excitement among the Shiba Inu crowd, including marketing lead Lucie.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Imagine President Trump at McDonald's: Here's your order, and don't worry, we're making America great again—one Shib at a time! &#x1f415;&#x1f354; <a href="https://twitter.com/hashtag/Trump2024?src=hash&amp;ref_src=twsrc%5Etfw">#Trump2024</a> <a href="https://twitter.com/hashtag/ShibArmySupports?src=hash&amp;ref_src=twsrc%5Etfw">#ShibArmySupports</a> <a href="https://twitter.com/hashtag/DriveThruDonald?src=hash&amp;ref_src=twsrc%5Etfw">#DriveThruDonald</a> <a href="https://t.co/l6Aq30v58t">https://t.co/l6Aq30v58t</a>
&mdash; Kaal (@kaaldhairya) <a href="https://twitter.com/kaaldhairya/status/1848568420742099260?ref_src=twsrc%5Etfw">October 22, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
See Also: <a href="https://www.benzinga.com/markets/cryptocurrency/24/10/41443187/amid-kamala-harris-trump-polymarket-hype-cftc-chair-wary-of-turning-into-an-election-cop-w">Amid Kamala Harris-Trump Polymarket Hype, CFTC Chair Wary Of Turning Into An &#8216;Election Cop&#8217; — Wants Congress To Make Moves On Crypto And Election Betting</a>
Why It Matters: The Shiba Inu team <a href="https://www.benzinga.com/markets/cryptocurrency/24/10/41324354/shiba-inu-announces-new-partnership-to-build-the-financial-layer-of-upcoming-shib-state-ke">announced a new partnership</a> with financial solutions company Mass last week to build the finance layer of the ambitious ‘Shiba State'.
Apart from the more popular meme coin narrative, Shiba Inu has made attempts to become a serious blockchain-based project with a complex financial system.&nbsp;
The team has worked on Shibarium, a Layer-2 blockchain, decentralized exchange ShibaSwap, and Shib The Metaverse in recent years in a bid to shed the narrow ‘meme coin' tag.
Price Action: At the time of writing, Shiba Inu was exchanging hands at $0.00001856, down 3.41% in the last 24 hours, according to <a href="https://pro.benzinga.com/dashboard?_gl=1&#x2A;380nj0&#x2A;_ga&#x2A;MTEyOTAyOTcxMy4xNzEzMzY0NTYy&#x2A;_ga_V7ZK73W7N0&#x2A;MTcxNDk4MzIzMi42LjEuMTcxNDk4OTE0Ni4wLjAuMA..">data from Benzinga Pro</a>. Over the month, the second-largest meme token gained 26%.
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/10/41442996/brad-garlinghouse-defends-ripple-co-founders-donation-to-kamala-harris-while-top-crypto-an">Brad Garlinghouse Defends Ripple Co-Founder&#8217;s Donation To Kamala Harris While Top Crypto Analyst Throws XRP &#8216;Securities&#8217; Jibe</a></li>
</ul>

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

News

Markets

$BONE

$SHIB

Trump's McDonald's Visit Has Shiba Inu Community Flaunting Its Meme Game —  Kaal Dhairya Chimes In With 'One Shib At A Time' Reference

Elon Musk, Tesla Inc.&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>), and Warner Bros. Discovery, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBD#NASDAQ">WBD</a>) are facing a lawsuit filed by Alcon Entertainment, alleging copyright infringement <a href="https://www.benzinga.com/news/24/10/41350962/tesla-key-exec-says-we-robot-event-had-1-300-perfectly-safe-autonomous-trips-driving-over-2-000-gues">during Tesla&#8217;s robotaxi event</a>.
What Happened: The Los Angeles-based production company, known for &#8220;Blade Runner 2049,&#8221; has accused them of using an AI image generator to create promotional art for Tesla&#8217;s &#8220;We, Robot&#8221; event, <a href="https://www.theverge.com/2024/10/21/24276092/alcon-entertainment-blade-runner-2049-tesla-musk-warner-bros-discovery-copyright">reported</a> The Verge.
The artwork allegedly bears a striking resemblance to&nbsp;stills from the 2017 sci-fi&nbsp;film, Blade Runner 2049, the copyright of which is owned by Alcon.
The lawsuit claims that Tesla and Warner Bros. sought permission&nbsp;to use imagery from the&nbsp;film just hours before the event, which was held&nbsp;on the Warner Bros. lot&nbsp;in California.
See Also:&nbsp;<a href="https://www.benzinga.com/news/24/10/41420451/openais-chinese-cousins-alibaba-and-bytedance-are-slashing-ai-costs-and-defying-us-chip-sanctions-be?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">OpenAI&#8217;s Chinese Cousins Alibaba, And ByteDance Are Slashing AI Costs And Defying US Chip Sanctions: Beijing&#8217;s Strength Is To &#8216;Build Fast, Build Reliably And Build Cheap&#8217;</a>
However, Alcon denied the request due to concerns about being associated with Musk and Tesla, citing Musk&#8217;s <a href="https://www.benzinga.com/news/24/02/37301290/elon-musk-is-still-attempting-to-defend-hateful-speech-amid-xs-growing-pains-and-public-backlash-rep">controversial behavior</a>, which they viewed as detrimental to their brand.
&#8220;Any prudent brand considering any Tesla partnership has to take Musk's massively amplified, highly politicized, capricious and arbitrary behavior, which sometimes veers into hate speech, into account,&#8221; the suit states. &#8220;Alcon did not want BR2049 to be affiliated with Musk, Tesla, or any Musk company, for all of these reasons.&#8221;
Despite Alcon&#8217;s refusal, Tesla allegedly used&nbsp;shots from Blade Runner 2049&nbsp;to create a stylized image displayed prominently during the event. Alcon also alleged that it was not informed about any agreements between Tesla and Warner Bros. that were necessary before the event.
The production company believes that these agreements&nbsp;included a promotional element that connected Tesla&#8217;s&nbsp;Cybercab with one or more&nbsp;films from the studio&#8217;s catalog.
The lawsuit does not specify the amount of damages sought, but it asserts that Musk, Tesla, and Warner Bros. were aware of&nbsp;the unauthorized nature of the&nbsp;image and its improper use.
Tesla and WBD did not immediately respond to <a href="https://pro.benzinga.com/dashboard">Benzinga&#8217;s</a> request for comments.
Why It Matters: At the Tesla &#8220;We, Robot&#8221; event earlier this month, the EV giant <a href="https://www.benzinga.com/news/24/10/41284847/tesla-reveals-two-seater-cybercab-that-drives-itself">unveiled&nbsp;its two-seater robotaxi</a>, the Cybercab. The event also featured the company&#8217;s humanoid robots.
Following the highly anticipated Robotaxi Day, analysts suggest that <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/10/41295072/tesla-robotaxi-day-event-more-fanfare-than-substance-8-analysts-on-cybercab-optimus">Tesla&#8217;s stock may continue to decline</a> due to the absence of clear business plans for robotaxis and the lack of updates on a more affordable production vehicle.
The Optimus robots came under fire recently when it was disclosed that engineers were <a href="https://www.benzinga.com/news/24/10/41354482/tesla-engineer-admits-optimus-robots-were-human-assisted-to-some-extent-at-robotaxi-unveiling-event">operating them remotely</a> during a demonstration. The event featured the robots displaying their skills by dancing and serving drinks, leading some critics to describe the presentation as deceptive.
Despite criticism and skepticism surrounding Tesla&#8217;s Optimus robots, Nvidia Corp. executive Rev Lebaredian <a href="https://www.benzinga.com/news/24/10/41401752/nvidia-executive-defends-teslas-optimus-robots-amid-criticism-thats-a-huge-advancement-not-something">defended the technology</a>, underscoring the complexity and technological prowess involved in controlling these robots.
Image via Shutterstock
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/esg/24/10/41426513/plug-power-evgo-enovix-analyst-clean-tech-picks-for-navigating-election-exposure-hedging-uncertainty?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Plug Power, EVgo, Enovix: Analyst Clean Tech Picks For Navigating Election Exposure, Hedging Uncertainty</a></li>
</ul>
Disclaimer: This content was partially produced with the help of&nbsp;<a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a>&nbsp;and was reviewed and published by Benzinga editors.

Entertainment

Legal

Tech

Media

TSLA

Elon Musk Faces Legal Challenge Over AI-Generated 'Blade Runner 2049' Imagery Use At 'We Robot' Event: Alcon Cites 'Highly Politicized, Capricious And Arbitrary Behavior'

3M Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMM#NYSE">MMM</a>) will release earnings results for its third quarter, before the <a href="https://www.benzinga.com/quote/MMM/earnings">opening bell on Tuesday, Oct. 22</a>.
Analysts expect the Saint Paul, Minnesota-based company to report quarterly earnings at $1.9 per share, down from $2.44 per share in the year-ago period. 3M projects to report revenue of $6.06 billion for the quarter, compared to $7.32 billion a year earlier, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
On Aug. 1, 3M named Anurag Maheshwari as Executive Vice President and CFO.
3M shares fell 0.2% to close at $134.84 on Monday.
Benzinga readers can access the latest analyst ratings on the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">Analyst Stock Ratings</a> page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let's have a look at how Benzinga's most-accurate <a href="https://www.benzinga.com/quote/MMM/analyst-ratings">analysts have rated the company</a> in the recent period.
<ul>
<li>Mizuho analyst Brett Linzey maintained a Neutral rating and raised the price target from $105 to $146 on Oct. 17. This analyst has an accuracy rate of 74%.</li>
<li>Barclays analyst Julian Mitchell maintained an Overweight rating and raised the price target from $145 to $160 on Oct. 2. This analyst has an accuracy rate of 77%.</li>
<li>Deutsche Bank analyst Nicole Deblase upgraded the stock from Hold to Buy and boosted the price target from $110 to $150 on July 31. This analyst has an accuracy rate of 81%.</li>
<li>Argus Research analyst John Eade upgraded the stock from Hold to Buy with a price target of $145 on July 30. This analyst has an accuracy rate of 77%.</li>
<li>Citigroup analyst Andrew Kaplowitz maintained a Neutral rating and raised the price target from $100 to $133 on July 29. This analyst has an accuracy rate of 85%.</li>
</ul>
Considering buying MMM stock? Here&#8217;s what analysts think:
Read This Next:<a href="https://www.benzinga.com/news/24/10/41429862/this-analyst-with-85-accuracy-rate-sees-around-11-upside-in-netflix-here-are-5-stock-picks-for-last"> </a>
<ul>
<li><a href="https://www.benzinga.com/news/24/10/41429862/this-analyst-with-85-accuracy-rate-sees-around-11-upside-in-netflix-here-are-5-stock-picks-for-last">This Analyst With 85% Accuracy Rate Sees Around 11% Upside In Netflix &#8211; Here Are 5 Stock Picks For Last Week From Wall Street&#8217;s Most Accurate Analysts</a></li>
</ul>

Earnings

Price Target

Pre-Market Outlook

Analyst Ratings

Trading Ideas

3M Gears Up For Q3 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

Tesla Inc.&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) recent unveiling of its robotaxi has left investors unimpressed, leading to concerns about the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/10/41436349/tesla-q3-earnings-preview-analyst-says-1-8-million-unit-estimate-hittable-for-2024-">company&#8217;s future growth prospects</a>.
What Happened: The lack of clarity surrounding the robotaxi technology has shifted the focus back to Tesla&#8217;s core operations, according to Jefferies, <a href="https://www.investing.com/news/stock-market-news/tesla-looks-like-an-imbalanced-vc-portfolio-jefferies-says-3674229?ref=biztoc.com">reported</a> Investing.com on Monday. This has raised concerns about the company&#8217;s governance and funding prospects in the medium term.
Jefferies, while raising Tesla&#8217;s price target to $195 from $165, has maintained a Neutral rating. The firm predicts an increase in cash flow over the next two years but warns of &#8220;subdued growth&#8221; for at least two years due to the aging of Tesla&#8217;s core models and the company&#8217;s struggle to update its vehicle catalog.
The brokerage expressed disappointment with Tesla&#8217;s Cybercab reveal, citing a lack of &#8220;tangible progress&#8221; on the technology and minimal details on income generation plans. This has refocused attention on Tesla&#8217;s core auto business, which is grappling with slowing deliveries and is expected to record its first annual drop in deliveries in 2024.
See Also: <a href="https://www.benzinga.com/insights/options/24/10/41411253/palantir-technologies-unusual-options-activity?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Palantir Technologies Unusual Options Activity</a>
Jefferies analysts described Tesla as an &#8220;imbalanced VC portfolio solely funded by an auto business under pressure.&#8221; The company is set to report its <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/10/41436349/tesla-q3-earnings-preview-analyst-says-1-8-million-unit-estimate-hittable-for-2024-">third-quarter earnings on Wednesday</a>. Tesla&#8217;s stock took a hit earlier in October following the underwhelming robotaxi reveal and missed third-quarter delivery expectations.
Why It Matters: Tesla&#8217;s recent challenges are part of a larger narrative. The company has been offering discounts of up to $4,000 on select Model Y and Model 3 vehicles in the U.S. in a bid to avoid its <a href="https://www.benzinga.com/news/24/10/41443856/tesla-offers-discounts-of-up-to-4k-on-select-model-3-y-vehicles-as-it-looks-to-avert-1st-ever-declin">first-ever decline in annual deliveries</a>. 
The company&#8217;s third-quarter earnings, <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/10/41436349/tesla-q3-earnings-preview-analyst-says-1-8-million-unit-estimate-hittable-for-2024-">which are due to be reported</a>, could provide more insight into demand and the strategy for the upcoming Cybercab.
Some analysts have also noted a shift in focus back to Tesla&#8217;s core business fundamentals after Robotaxi Day, suggesting that the company may be <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/10/41429320/while-elon-musk-likely-to-face-questions-about-robotaxi-during-earnings-call-some-a">redirecting its attention</a> away from the underwhelming robotaxi presentation.
Price Action: Tesla&#8217;s stock closed at $218.85 on Monday, down 0.84% for the day. In after-hours trading, the stock slipped an additional 0.16%. Year to date, Tesla&#8217;s stock has fallen 11.90%, according to <a href="https://www.benzinga.com/pro/">data from Benzinga Pro</a>.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/equities/24/10/41422633/investors-lost-over-95-of-their-wealth-in-this-nvidia-linked-etf-while-jensen-huang-led-chip-gia?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Investors Lost Over 95% Of Their Wealth In This Nvidia-Linked ETF While Jensen Huang-Led Chip Giant Gained 220% In The Past Year: Here&#8217;s More</a></li>
</ul>
Photo courtesy: Tesla
This story was generated using <a href="https://www.benzinga.com/author/benzinga-neuro">Benzinga Neuro</a> and edited by <a href="https://www.benzinga.com/topic/Kaustubh-Bagalkote" target="_blank" rel="noreferrer noopener">Kaustubh Bagalkote</a>

Analyst Color

Equities

Tesla Robotaxi Reveal Falls Flat Amid Lack Of Clarity, Shifting Focus Back On Elon Musk-Led EV Giant's 'Under Pressure' Auto Business: Analysts Warn Of 'Subdued Growth' For 2 Years

FSLY

Fastly Launches New DDoS Protection Solution To Safeguard Applications And APIs From Disruptive Attacks

User experiences, sustainability, scalability key strategic factors for choosing Juniper automated WAN for new IP-based infrastructure

JNPR

Juniper Networks Selected By Norwegian Broadcasting For Scalable IP Infrastructure To Enhance Digital Media

Gogo Galileo HDX is expected to be available on the Citation Longitude beginning early 2026. Timing on the other aircraft will be announced at a later date.

Reported Earlier, Textron Aviation Integrates Gogo Galileo HDX Across Citation Fleet

Skanska has signed an additional contract with Columbia Memorial Hospital for a hospital expansion project in&nbsp;Astoria, Oregon, USA. The contract is worth&nbsp;USD 153M, about&nbsp;SEK 1.6 billion, which will be included in the US order bookings for the&nbsp;fourth quarter&nbsp;of 2024.

SKBSY

Skanska Secures Additional $153M Contract For Columbia Memorial Hospital Expansion In Astoria, Oregon

Reported Earlier, Century Communities Expands New Home Offerings With Launch Of Multiple Developments In The Greater Nashville Area

Thoughtworks&nbsp;, a global technology consultancy that integrates strategy, design and engineering, announces a pioneering collaboration with&nbsp;<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fau.swann.com%2Fcompany%2Fabout-swann%2F&amp;esheet=54138599&amp;newsitemid=20241022590057&amp;lan=en-US&amp;anchor=Swann&amp;index=2&amp;md5=32192ee2410dd76afd4516c82739c4b7">Swann</a>&nbsp;to develop SwannShield&trade; &ndash; an innovative AI-powered home security voice assistant. A leading global provider of security monitoring, consumer electronics and security-centric solutions, Swann empowers people to protect and stay connected to their home or business no matter where life takes them. 
Alex Talevski, CEO at Swannsaid, &quot;Thoughtworks&#39; pioneering contribution helped bring our idea of SwannShield&trade; to life and stress test the product in its critical initial phase. Thoughtworks&#39; vital contribution in building the prototypes enabled us to progress our SwannShield&trade; product and launch it in the market.&quot;

TWKS

Reported Earlier, Thoughtworks And Swann Introduce SwannShield Transforming Home Security With AI-Powered Real-Time Voice Assistant Technology

CXone Mpower revolutionizes AI for customer service on a unified hyper platform, enabling enterprises to design, build and operate automation for workflows, agents and knowledge at scale and precision

NICE

NICE Expands CXone Mpower Transforms Customer Service With AI-Powered Automation Across All Touchpoints

Cellectis&nbsp;a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, announced today that they will be showcasing pre-clinical data that permit the design of an efficient and specific TALE base editors (TALEB) as well as a process to enhance the efficacy of non-viral gene insertion in hematopoietic stem and progenitor cells (HSPCs) at the European Society of Cell and Gene Therapy 31st&nbsp;annual congress, that will take place on October 22-25, 2024, in Roma, Italy.

CLLS

Cellectis To Reveal Data On TALE-Based Editors And Non-Viral Gene Therapies At The 31st Annual ESGCT Congress

&quot;During this period of market uncertainty, we successfully connected multiple buyers with their respective lenders to fulfill the portfolio closing requirements for the seller, with minimal contingencies and securing non-refundable earnest money,&quot; said Ebrahim Valliani, first vice president investments in Marcus &amp; Millichap&#39;s Chicago Oak Brook office. &quot;We delivered the confidence that the sellers needed for a successful and reliable transaction.&quot; Valliani represented the seller, Skyline Investments Inc., and procured the buyers, with support from Chris Gomes, Allan Miller and Michael Klar of the Miller-Gomes Hotel Team of Marcus &amp; Millichap.

Reported Earlier, Marcus & Millichap Closes $101M Sale Of 11-Property Courtyard Hotel Portfolio Across Seven U.S. States

With U.S. stock futures trading lower this morning on Tuesday, some of the stocks that may grab investor focus today are as follows:
<ul>
<li>Wall Street expects General Motors Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GM#NYSE">GM</a>) to report quarterly earnings at $2.43 per share on revenue of $44.59 billion before the opening bell, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>. GM shares gained 0.8% to $49.31 in after-hours trading.</li>
<li>Zions Bancorporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZION#NASDAQ">ZION</a>) reported better-than-expected financial results for the third quarter on Monday. Zions Bancorporation shares gained 3.2% to $51.00 in the after-hours trading session.</li>
<li>Analysts are expecting Verizon Communications Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VZ#NYSE">VZ</a>) to post quarterly earnings at $1.18 per share on revenue of $33.43 billion. The company will release earnings before the markets open. Verizon shares gained 0.4% to $43.86 in after-hours trading.</li>
</ul>
Check out our <a href="https://www.benzinga.com/premarket/">premarket coverage here</a>
<ul>
<li>RLI Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RLI#NYSE">RLI</a>) reported stronger-than-expected earnings and sales results for the third quarter on Monday. The company reported quarterly earnings of $1.31 per share which beat the analyst consensus estimate of 98 cents per share. The company reported quarterly sales of $401.544 million which beat the analyst consensus estimate of $389.487 million. RLI shares gained 1.2% to $164.00 in the after-hours trading session.</li>
<li>Analysts expect Lockheed Martin Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LMT#NYSE">LMT</a>) to report quarterly earnings at $6.50 cents per share on revenue of $17.35 billion before the opening bell. Lockheed Martin shares rose 0.3% to $616.50 in after-hours trading.</li>
</ul>
Check This Out:
<ul>
<li><a href="https://www.benzinga.com/news/24/10/41429862/this-analyst-with-85-accuracy-rate-sees-around-11-upside-in-netflix-here-are-5-stock-picks-for-last">This Analyst With 85% Accuracy Rate Sees Around 11% Upside In Netflix &#8211; Here Are 5 Stock Picks For Last Week From Wall Street&#8217;s Most Accurate Analysts</a></li>
</ul>
Photo courtesy: Shutterstock

ZION

General Motors, Verizon And 3 Stocks To Watch Heading Into Tuesday

<ul>
<li>Enhanced protection of vision with ANX007 treatment in healthier eyes</li>
<li>Greater preservation of EZ in the central fovea by ANX007 in patients with less advanced GA</li>
<li>Pivotal Phase 3 ARCHER II Data Expected Second Half 2026</li>
</ul>

ANNX

Reported Earlier, Annexon Presents Phase 2 Data On ANX007 In Dry AMD Patients With Less Advanced GA At AAO 2024

EV giant Tesla Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) is now offering discounts of up to $4000 on select inventory Model Y and Model 3 vehicles in the U.S. as it looks to avert recording its <a href="https://www.benzinga.com/general/education/24/10/41166723/how-many-evs-has-tesla-delivered-produced-each-quarter-a-look-at-the-results-since-2019">first-ever decline in annual deliveries.</a>
What Happened: An inventory 2024 Model Y Long Range rear-wheel drive is now priced at $41,390 on Tesla&#8217;s website, down from its original starting price of $44,990.
The starting price on a Model 3 Long Range rear-wheel drive variant, meanwhile, is $40,010, <a href="https://www.benzinga.com/news/24/04/38285714/no-more-inventory-discounts-on-tesla-cars-as-ceo-elon-musk-says-sales-system-has-turned-complex-and">down from its original price</a> of $43,490. 
Why It Matters: Tesla delivered 462,890 vehicles&nbsp;in the third quarter, up 6.4% from a year earlier, but still short of estimates. 
The company is currently at risk of reporting its first-ever decline in annual deliveries, particularly after deliveries fell 8.5% year-on-year in the first quarter and 4.8% in the second quarter.
For the full-year 2023, Tesla delivered 1,808,581 vehicles. To mark a growth over last year, the company has to deliver at least 514,926 vehicles in the three months through the end of December.
Price Action: Tesla stock closed 0.84% lower on Monday, at $218.85. Year-to-date, the EV giant&#8217;s shares are down 11.90%, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro data</a>.
Check out more of Benzinga&#8217;s Future Of Mobility coverage by&nbsp;<a href="https://www.benzinga.com/topic/mobility" target="_blank" rel="noreferrer noopener">following this link.</a>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/24/10/41422292/spacex-ceo-elon-musk-slams-overregulation-in-space-travel-as-he-campaigns-for-trump-if-starship-did">SpaceX CEO Elon Musk Slams Overregulation In Space Travel As He Campaigns For Trump: &#8216;If Starship Did Hit A Whale, Honestly, It&#8217;s Like The Whale Had It Coming&#8217;</a></li>
</ul>
Photo courtesy: Shutterstock

Tesla Offers Discounts Of Up To $4K On Select Model 3, Y Vehicles As It Looks To Avert 1st-Ever Decline In Annual Deliveries

<ul>
<li>Under the revised agreement, both companies will co-develop four Radio-DARPin programs; each company will have the right to commercialize two programs (previously one each)</li>
<li>Molecular Partners will hold commercial rights to the second nominated Radio-DARPin Candidate, in addition to rights to first program MP0712 targeting DLL3</li>
</ul>

MOLN

Molecular Partners And Orano Med Expand Collaboration To Co-Develop 212Pb-Based Radio-DARPin Therapeutics

Through its investment in Formic Technologies, Mitsubishi Electric aims to develop a new business model that evolves its automation solutions into more accessible formats for its customers going forward.

MIELF

MIELY

Reported Earlier, Mitsubishi Electric's ME Innovation Fund Backs Formic Technologies To Revolutionize Industrial Robotics With Subscription Model

The Federal Trade Commission has enforced a new rule that prohibits the sale or purchase of fake reviews, in a move to maintain the integrity of online reviews and testimonials. The rule, which took effect on Monday, will enable the FTC to impose civil penalties on <a href="https://www.benzinga.com/news/24/10/41393515/ftc-click-to-cancel-rule-makes-it-easy-to-end-subscriptions-what-it-means-for-netflix-planet-fitness">those who knowingly breach it</a>.
What Happened: The FTC&#8217;s new rule, <a href="https://www.ftc.gov/news-events/news/press-releases/2024/08/federal-trade-commission-announces-final-rule-banning-fake-reviews-testimonials">announced</a> in August, aims to curb the proliferation of fake reviews and testimonials that mislead consumers and unfairly disadvantage honest competitors. 
The rule specifically targets reviews attributed to non-existent individuals, those generated by artificial intelligence, or those that misrepresent the reviewer&#8217;s experience.
Businesses are also prohibited from creating or selling fake reviews. Those found to be in violation, including businesses that knowingly purchase fake reviews or use intimidation tactics, will face penalties.
&#8220;As of today, @FTC&#8217;s final rule banning fake online reviews and testimonials has come into effect,&#8221; wrote FTC Chair Lina Khan in a post on X. 
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">As of today, <a href="https://twitter.com/FTC?ref_src=twsrc%5Etfw">@FTC</a>&#39;s final rule banning fake online reviews and testimonials has come into effect. If you encounter any of these prohibited practices, you can report them to <a href="https://twitter.com/FTC?ref_src=twsrc%5Etfw">@FTC</a> at: <a href="https://t.co/k0O6juZImU">https://t.co/k0O6juZImU</a> <a href="https://t.co/I2Rf0b9xTH">https://t.co/I2Rf0b9xTH</a> <a href="https://t.co/60qp2cRJMU">pic.twitter.com/60qp2cRJMU</a>
&mdash; Lina Khan (@linakhanFTC) <a href="https://twitter.com/linakhanFTC/status/1848423333702078550?ref_src=twsrc%5Etfw">October 21, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
See Also: <a href="https://www.benzinga.com/markets/equities/24/10/41421309/tesla-investor-ross-gerber-calls-it-game-over-as-googles-waymo-expands-robotaxi-presence-in-west?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Tesla Investor Ross Gerber Calls It &#8216;Game Over&#8217; As Google&#8217;s Waymo Expands Robotaxi Presence In West LA</a>
Why It Matters: This new rule is part of a series of initiatives led by Khan to ensure fair and transparent business practices. Earlier in September, Khan <a href="https://www.benzinga.com/markets/equities/24/09/41019443/ftc-chair-lina-khan-warns-airlines-may-exploit-ai-for-price-discrimination-raising-concerns-over">raised concerns</a> about the potential misuse of AI by airlines to charge higher prices for vulnerable travelers. 
In October, the FTC also finalized a rule called &#8220;click-to-cancel,&#8221; aimed at <a href="https://www.benzinga.com/news/24/10/41393515/ftc-click-to-cancel-rule-makes-it-easy-to-end-subscriptions-what-it-means-for-netflix-planet-fitness">simplifying subscription cancellations</a>.
The FTC, under Khan&#8217;s leadership, is also under pressure to block the <a href="https://www.benzinga.com/general/biotech/24/10/41277809/ftc-faces-pressure-to-block-novo-nordisk-catalent-merger-over-antitrust-fears">proposed $16.5 billion acquisition</a> of Catalent Inc by Novo Nordisk A/S due to antitrust concerns.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/24/10/41415466/obama-criticizes-trumps-town-hall-appearance-at-arizona-rally-you-would-be-worried-if-your-grandpa-w?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Obama Criticizes Trump&#8217;s Town Hall Appearance At Arizona Rally: &#8216;You Would Be Worried If Your Grandpa Was Acting Like This&#8217;</a></li>
</ul>
Image Via Shutterstock 
This story was generated using <a href="https://www.benzinga.com/author/benzinga-neuro">Benzinga Neuro</a> and edited by <a href="https://www.benzinga.com/topic/Kaustubh-Bagalkote" target="_blank" rel="noreferrer noopener">Kaustubh Bagalkote</a>

FTC Rule To Protect Consumers From Fake Reviews, AI-Generated Testimonials Comes Into Effect: What You Need To Know

Walt Disney Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIS#NYSE">DIS</a>) has ceased allowing customers to subscribe to Hulu and Disney+ via Apple Inc.&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) App Store, thereby avoiding the iPhone maker&#8217;s in-app purchase fees.
What Happened: The entertainment giant is no longer allowing new or returning subscribers to register and pay for these services through&nbsp;the App Store. However, this change will not impact existing subscribers who are billed through Apple.
Disney is now guiding customers to its websites to view all plans and directly&nbsp;sign up for a subscription. This strategy enables Disney to bypass the&nbsp;15% to 30% fee&nbsp;that Apple imposes for each transaction made via in-app purchases.
See Also:&nbsp;<a href="https://www.benzinga.com/news/24/10/41442330/jeff-bezos-would-have-named-amazon-as-relentless-but-then-someone-said-it-sounded-sinister-hes-since?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Jeff Bezos Would Have Named Amazon As &#8216;Relentless&#8217; But Then Someone Said It Sounded Sinister — He&#8217;s Since Built A Business Empire That Knows No Limits</a>
This move is in line with Disney&#8217;s latest price increases that came&nbsp;into effect on Oct. 17.&nbsp;The cost of Disney+ plans rose&nbsp;by $2, while Hulu with&nbsp;ads and without ads experienced a $2 and $1 increase, respectively.
The removal of in-app purchase fees seems to be a part of Disney&#8217;s plan to improving streaming revenue, along with price hikes and&nbsp;a recent crackdown on password&nbsp;sharing.
In August, Disney released its financial results for the <a href="https://www.benzinga.com/news/earnings/24/08/40218880/disneys-q3-earnings-revenue-and-eps-beat-streaming-business-turns-profitable-strong-espn-revenue-bo">third quarter of fiscal 2024</a>. For the first time, Disney&#8217;s streaming segment—which includes Disney+, Hulu, and ESPN+—achieved profitability, one quarter ahead of projections.
The streaming division reported an operating profit of $47 million, a notable turnaround from a $512 million loss in the same period last year.
However, when excluding ESPN+, the direct-to-consumer streaming unit still recorded a $19 million loss. Meanwhile, revenue from Disney's traditional TV networks fell by 7%.
Subscribe to the&nbsp;<a href="https://bztechtrends.beehiiv.com/subscribe" target="_blank" rel="noreferrer noopener">Benzinga Tech Trends newsletter</a>&nbsp;to get all the latest tech developments delivered to your inbox.
Why It Matters: Disney's move to halt subscription sign-ups for Hulu and Disney+ via Apple's App Store reflects a broader trend of tech companies pushing back against Apple's in-app purchase policies.
Earlier this year, in January, the Supreme Court gave a decision that <a href="https://www.benzinga.com/government/24/01/36646078/supreme-court-decision-shakes-up-apples-app-store-opens-door-for-cheaper-app-purchases">rejected Apple&#8217;s appeal</a> in an antitrust lawsuit concerning its App Store. The ruling, which also involved Epic Games, the creator of Fortnite, could have a notable impact on Apple&#8217;s revenue.
Previously, Meta Platforms, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>), Microsoft Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>), and Match Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTCH#NASDAQ">MTCH</a>), the parent company of Tinder, have all <a href="https://www.benzinga.com/news/24/03/37863002/meta-and-microsoft-criticize-apple-for-evading-legal-requirements-post-epic-games-ruling">voiced strong opposition to Apple&#8217;s payment</a> policies.
In the second quarter of 2024, the Apple App Store reportedly generated $24.6 billion in revenue from users worldwide, more than twice the revenue earned by Android users through the Google Play Store.
Projections indicate that by 2027, the Apple App Store could bring in approximately $125 billion in global revenue, while the Google Play Store is expected to reach $60 billion in revenue from subscriptions and in-app purchases, according to Statista.
Image: Shutterstock/ ymgerman
Check out more of Benzinga&#8217;s Consumer Tech coverage by&nbsp;<a href="https://www.benzinga.com/topic/consumer-tech" target="_blank" rel="noreferrer noopener">following this link</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/24/10/41418188/ai-power-demand-skyrockets-nvidia-ceo-lauds-openai-and-teslas-optimus-robots-assisted-by-humans-this?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">AI Power Demand Skyrockets, Nvidia CEO Lauds OpenAI, And Tesla&#8217;s Optimus Robots Assisted By Humans: This Week In AI</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with the help of&nbsp;<a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a>&nbsp;and was reviewed and published by Benzinga editors.

AAPL

MSFT

MTCH

Disney+ And Hulu Stream Away From Apple's 30% Toll Bridge: What It Means For The iPhone Maker?

Aptevo Therapeutics announces $2.75M offering priced at-the-market

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Pre-market stock movers are worth checking out as we dive into all of the biggest news sending shares higher and lower on Wednesday morning!



Moving stocks are merger plans, a new contract, a CEO departure and more.



Let&rsquo;s get into that news below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>Gabelli Multi-Media Trust Inc. (The) Rights (expiring July 22, 2024) Rights (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GGTR#NYSE">GGTR</a>) stock is rocketing 110% as the <a href="https://www.nasdaq.com/press-release/gabelli-multimedia-trust-alerts-common-stock-shareholders-rights-offering-expiration">rights offering expiration date closes in</a>.</li>



<li>Aditxt (NASDAQ:<a href="https://investorplace.com/stock-quotes/adtx-stock-quote/">ADTX</a>) shares are soaring more than 79% on an <a href="https://www.nasdaq.com/press-release/aditxt-and-evofem-amend-and-restate-merger-agreement-targeting-september-30-closing">amended merger agreement</a>.</li>



<li>Shimmick (NASDAQ:<a href="https://investorplace.com/stock-quotes/shim-stock-quote/">SHIM</a>) stock is surging over 56% on a <a href="https://www.marketwatch.com/story/shimmick-shares-surge-on-27-6-million-california-contract-121fe14b?mod=investing">$27.6 million contract</a>.</li>



<li>Aura Fat Projects (NASDAQ:<a href="https://investorplace.com/stock-quotes/afar-stock-quote/">AFAR</a>) shares are gaining more than 33% without any clear news this morning.</li>



<li>MicroAlgo (NASDAQ:<a href="https://investorplace.com/stock-quotes/mlgo-stock-quote/">MLGO</a>) stock is increasing over 22% with heavy pre-market trading.</li>



<li>Aptevo Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/apvo-stock-quote/">APVO</a>) shares are rising more than 18% with strong pre-market trading.</li>



<li>GitLab (NASDAQ:<a href="https://investorplace.com/stock-quotes/gtlb-stock-quote/">GTLB</a>) stock is climbing close to 16% higher on <a href="https://finance.yahoo.com/news/exclusive-google-backed-software-developer-060252892.html">reports it&rsquo;s considering a sale</a>.</li>



<li>Bloom Energy (NYSE:<a href="https://investorplace.com/stock-quotes/be-stock-quote/">BE</a>) shares are heading over 14% higher on a new <a href="https://finance.yahoo.com/news/bloom-energy-coreweave-partner-revolutionize-200500337.html">artificial intelligence (AI) data center partnership</a>.</li>



<li>Immersion (NASDAQ:<a href="https://investorplace.com/stock-quotes/immr-stock-quote/">IMMR</a>) stock is jumping nearly 12% this morning.</li>



<li>Eledon Pharmaceuticals&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/eldn-stock-quote/">ELDN</a>) shares are up more than 11% this morning.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>Five Below (NASDAQ:<a href="https://investorplace.com/stock-quotes/five-stock-quote/">FIVE</a>) stock is diving over 16% with the <a href="https://www.nasdaq.com/press-release/five-below-inc-announces-ceo-transition-2024-07-16">departure of its CEO</a>.</li>



<li>New Horizon Aircraft (NASDAQ:<a href="https://investorplace.com/stock-quotes/hovr-stock-quote/">HOVR</a>) shares are tumbling more than 13% after <a href="https://www.nasdaq.com/press-release/horizon-aircraft-attend-farnborough-international-airshow-2024-2024-07-15">rallying yesterday on airshow plans</a>.</li>



<li>QXO (NASDAQ:<a href="https://investorplace.com/stock-quotes/qxo-stock-quote/">QXO</a>) stock is taking an over 12% beating on Wednesday morning.</li>



<li>Greenpro Capital (NASDAQ:<a href="https://investorplace.com/stock-quotes/grnq-stock-quote/">GRNQ</a>) shares are sliding more than 12% after <a href="https://www.accesswire.com/888710/greenpro-capital-corp-and-green-x-corp-forms-strategic-alliance-with-bank-islam-trust-company-labuan-ltd">jumping yesterday on strategic alliance news</a>.</li>



<li>Cineverse (NASDAQ:<a href="https://investorplace.com/stock-quotes/cnvs-stock-quote/">CNVS</a>) stock is dropping over 10% on Wednesday.</li>



<li>Virpax Pharmaceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/vrpx-stock-quote/">VRPX</a>) shares are decreasing almost 10% after rallying yesterday.</li>



<li>Volato (NYSEMKT:<a href="https://investorplace.com/stock-quotes/soar-stock-quote/">SOAR</a>) stock is falling more than 9% after a similar rally yesterday.</li>



<li>Eightco (NASDAQ:<a href="https://investorplace.com/stock-quotes/octo-stock-quote/">OCTO</a>) shares are slipping over 9% <a href="https://www.stocktitan.net/news/OCTO/eightco-provides-shareholder-8okhfyrirfyb.html">following a shareholder update</a>.</li>



<li>Xeris Biopharma (NASDAQ:<a href="https://investorplace.com/stock-quotes/xers-stock-quote/">XERS</a>) stock is dipping more than 9% on Wednesday morning.</li>



<li>Logistic Properties of The Americas (NYSEMKT:<a href="https://investorplace.com/stock-quotes/lpa-stock-quote/">LPA</a>) shares close out our pre-market stock movers down 9% after a recent rally.</li>
</ol>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/07/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-wednesday-july-17th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Pre-market stock movers are worth diving into this morning and we have all of the hottest news worth checking out on Thursday!



Moving stocks this morning are an acquisition deal, a clinical trial launch, earnings reports and more.



Let&rsquo;s get into that news below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>Chuy&rsquo;s (NASDAQ:<a href="https://investorplace.com/stock-quotes/chuy-stock-quote/">CHUY</a>) stock is rocketing more than 46% on a <a href="https://www.nasdaq.com/press-release/darden-restaurants-acquire-chuys-holdings-inc-approximately-605-million-transaction">$605 million acquisition deal</a>.</li>



<li>Onconetix (NASDAQ:<a href="https://investorplace.com/stock-quotes/onco-stock-quote/">ONCO</a>) shares are soaring over 43% alongside heavy pre-market trading.</li>



<li>Apollomics (NASDAQ:<a href="https://investorplace.com/stock-quotes/aplm-stock-quote/">APLM</a>) stock is surging more than 25% with strong early morning trading.</li>



<li>Bionomics (NASDAQ:<a href="https://investorplace.com/stock-quotes/bnox-stock-quote/">BNOX</a>) shares are rising over 23% as it <a href="https://www.nasdaq.com/press-release/bionomics-initiates-affirm-1-phase-3-clinical-trial-bnc210-social-anxiety-disorder">kicks off a Phase 3 clinical trial</a>.</li>



<li>Big Tree Cloud (NASDAQ:<a href="https://investorplace.com/stock-quotes/dsy-stock-quote/">DSY</a>) stock is increasing more than 18% with strong pre-market trading.</li>



<li>ZimVie (NASDAQ:<a href="https://investorplace.com/stock-quotes/zimv-stock-quote/">ZIMV</a>) shares are heading over 13% higher without any clear news on Thursday morning.</li>



<li>SAI.TECH Global (NASDAQ:<a href="https://investorplace.com/stock-quotes/sai-stock-quote/">SAI</a>) stock is gaining more than 12% on a <a href="https://www.globenewswire.com/news-release/2024/07/18/2914992/0/en/SAI-TECH-Global-Corporation-Announces-Share-Repurchase-Program.html">share repurchase program</a>.</li>



<li>MultiMetaVerse (NASDAQ:<a href="https://investorplace.com/stock-quotes/mmv-stock-quote/">MMV</a>) shares are climbing over 11% as it continues a recent rally.</li>



<li>Psyence Biomedical (NASDAQ:<a href="https://investorplace.com/stock-quotes/pbm-stock-quote/">PBM</a>) stock is jumping more than 10% despite a lack of news today.</li>



<li>XWELL (NASDAQ:<a href="https://investorplace.com/stock-quotes/xwel-stock-quote/">XWEL</a>) shares are up over 10% this morning.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>Leslies (NASDAQ:<a href="https://investorplace.com/stock-quotes/lesl-stock-quote/">LESL</a>) stock is diving more than 21% on <a href="https://www.nasdaq.com/press-release/leslies-inc-announces-preliminary-third-quarter-fiscal-2024-financial-results-and">preliminary earnings and guidance</a>.</li>



<li>Aptevo Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/apvo-stock-quote/">APVO</a>) shares are rumbling over 13% after a massive rally yesterday.</li>



<li>Domino&rsquo;s Pizza (NYSE:<a href="https://investorplace.com/stock-quotes/dpz-stock-quote/">DPZ</a>) stock is sliding more than 13% with the release of its <a href="https://ir.dominos.com/static-files/68ecdbfc-bd1c-486a-a574-d6f54b7e5132">Q2 earnings report</a>.</li>



<li>CBL International (NASDAQ:<a href="https://investorplace.com/stock-quotes/banl-stock-quote/">BANL</a>) shares are taking an over 12% beating on Thursday morning as it retreats from a rally yesterday.</li>



<li>WiMi Hologram Cloud (NASDAQ:<a href="https://investorplace.com/stock-quotes/wimi-stock-quote/">WIMI</a>) stock is dropping close to 12% after an unexpected rally yesterday.</li>



<li>Beyond Meat (NASDAQ:<a href="https://investorplace.com/stock-quotes/bynd-stock-quote/">BYND</a>) shares are falling more than 11% on <a href="https://www.wsj.com/articles/beyond-meat-engages-bondholders-for-restructuring-talks-7de6b8ae">restructuring talks with bondholders</a>.</li>



<li>American Rebel (NASDAQ:<a href="https://investorplace.com/stock-quotes/areb-stock-quote/">AREB</a>) stock is decreasing over 11% this morning after rallying on Wednesday.</li>



<li>Aditxt (NASDAQ:<a href="https://investorplace.com/stock-quotes/adtx-stock-quote/">ADTX</a>) shares are slipping more than 10% <a href="https://investorplace.com/2024/07/why-is-aditxt-adtx-stock-up-72-today/">following a rally yesterday</a>.</li>



<li>Stardust Power (NASDAQ:<a href="https://investorplace.com/stock-quotes/sdst-stock-quote/">SDST</a>) stock is dipping over 10% <a href="https://investorplace.com/2024/07/stardust-power-sdst-stock-pops-140-days-after-debut-what-to-know/">after a surprise rally yesterday</a>.</li>



<li>GRI Bio (NASDAQ:<a href="https://investorplace.com/stock-quotes/gri-stock-quote/">GRI</a>) shares close out our pre-market stock movers down more than 9%.</li>
</ol>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/07/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-thursday-july-18th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Aptevo Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/apvo-stock-quote/">APVO</a>) just reported results for the second quarter of 2024.<ul><li>Aptevo Therapeutics reported earnings per share of -$1.67. This was above the analyst estimate for EPS of -$3.92.</li><li>The company did not report any revenue for the quarter.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/earning-results/2024/08/apvo-stock-earnings-aptevo-therapeutics-for-q2-of-2024/">APVO Stock Earnings: Aptevo Therapeutics Beats EPS for Q2 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

APVO Stock Earnings: Aptevo Therapeutics Beats EPS for Q2 2024

Aptevo Therapeutics files to sell 13.51M shares of common stock

In a report released yesterday, Jonathan Aschoff from Roth MKM maintained a Buy rating on Aptevo Therapeutics (APVO – Research Report), with a pric...

Roth MKM Sticks to Their Buy Rating for Aptevo Therapeutics (APVO)

Warning: APVO is at high risk of performing badly

ADTX

AFAR

APLM

APVO

AREB

BANL

BNOX

BYND

CHUY

CNVS

ELDN

FIVE

GGTR

GRNQ

GTLB

HOVR

IMMR

LESL

MLGO

OCTO

ONCO

SDST

SHIM

SOAR

VRPX

WIMI

XERS

XWEL

ZIMV

Events

Press Releases

Aptevo Therapeutics Presenting at The Protein & Antibody Engineering Summit, Boston, MA

Aptevo Participating in the BIO International Convention

Aptevo Therapeutics Announces $2.75 Million Offering Priced At-the-Market Under Nasdaq Rules

Aptevo Therapeutics Announces Closing of $2.75 Million Offering

Aptevo Therapeutics Reports 2Q 2024 Financial Results and Provides a Business Update

Phase 1b/2 "RAINIER" Frontline Acute Myeloid Leukemia (AML) Trial Initiated

Aptevo Therapeutics and Alligator Bioscience to Present Positive Interim Phase 1 Data Evaluating ALG.APV-527 Monotherapy in Multiple Solid Tumor Types, at ESMO Congress 2024

Aptevo Therapeutics and Alligator Bioscience Announce Data from Phase 1 ALG.APV-527 Monotherapy Trial Showing 60% of Evaluable Patients Achieved Stable Disease in Solid Tumor Study

Aptevo Therapeutics Announces $3.0 Million Offering Priced At-the-Market Under Nasdaq Rules

Aptevo Therapeutics Announces Closing of $3.0 Million Offering Priced At-the-Market Under Nasdaq Rules

Comments

Aptevo Therapeutics

Aptevo Therapeutics (APVO) Opciones

Loading...

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL